Taiho Oncology, Inc.
This nomination goes to Chris Zergebel who represents a key function in our industry, Clinical Project Management. For the 9 years that I have known Chris Zergebel, he has worked tirelessly for Taiho Oncology in Clinical Operations & Project Management. Over the past 5 years Chris served as the Global Project Director for the development of a novel therapeutic for the treatment of patients with metastatic colorectal cancer. The product was the first FDA approved therapy for the US subsidiary where Chris has persistently collaborated with many stakeholders to achieve such a tremendous milestone for patients. Chris has demonstrated Heroism by taking the "long-view" and remaining part of a company and team throughout the complete life-cycle of development from early phase through commercialization of this important therapy. Chris' years of experience at one company working in a specific therapy areas generates enormous value for the pharma company and the patients the company serves.